Literature DB >> 25133449

Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.

Ji Ryang Kim1, Bo Hyun Kim, Sang Mi Kim, Min Young Oh, Won Jin Kim, Yun Kyung Jeon, Sang Soo Kim, Byung Joo Lee, Yong Ki Kim, In Ju Kim.   

Abstract

BACKGROUND: Vitamin D has recently attracted attention because reduced levels are associated with the prevalence and aggressiveness of several cancers. This study aimed to evaluate the relationship between preoperative serum 25 hydroxyvitamin D (25(OH) vitamin D) levels and clinicopathologic characteristics in female patients with papillary thyroid cancer (PTC).
METHODS: A total of 548 female patients who underwent total thyroidectomy for PTC between June 2012 and May 2013 were included. Blood samples were obtained within two weeks prior to surgery. Patients were categorized into four quartiles by preoperative serum 25(OH) vitamin D levels. The clinicopathologic features of PTC were analyzed retrospectively.
RESULTS: Preoperative 25(OH) vitamin D was significantly lower in patients with a tumor size of >1 cm (p = 0.041) or lymph node metastasis (LNM; p = 0.043). No significant trends in several clinicopathologic features were observed in relation to increasing serum vitamin D concentrations except decreasing tumor size (p = 0.010). Patients in the second quartile had a greater occurrence of T stage 3/4 (odds ratio (OR) 2.03 [confidence interval (CI) 1.19-3.44]; p = 0.009), LNM (OR 2.03 [CI 1.19-3.44]; p = 0.009), lateral LNM (OR 5.03 [CI 1.66-15.28]; p = 0.004), and extrathyroidal extension (ETE; OR 1.95 [CI 1.15-3.29]; p = 0.013) than those in the fourth quartile. Multivariate analysis showed that patients in the second quartile had a greater occurrence of T stage 3/4 (OR 1.89 [CI 1.08-3.30]; p = 0.026), LNM (OR 2.04 [CI 1.20-3.47]; p = 0.009), lateral LNM (OR 5.12 [CI 1.68-15.59]; p = 0.004), and ETE (OR 1.81 [CI 1.04-3.15]; p = 0.036) than those in the fourth quartile. When the subjects were recategorized into two groups by median 25(OH) vitamin D levels, those with values below the median had a significantly higher risk of T stage 3/4, LNM, lateral LNM, stage III/IV, and ETE. All values except ETE sustained significance after adjustment.
CONCLUSION: Lower preoperative serum 25(OH) vitamin D levels appear to be associated with poor clinicopathologic features in female patients with PTC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25133449     DOI: 10.1089/thy.2014.0090

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  23 in total

1.  Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis.

Authors:  M-J Hu; Q Zhang; L Liang; S-Y Wang; X-C Zheng; M-M Zhou; Y-W Yang; Q Zhong; F Huang
Journal:  J Endocrinol Invest       Date:  2018-02-20       Impact factor: 4.256

2.  VITAMIN D LEVEL AND ITS RELATIONSHIP WITH CANCER STAGE IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA.

Authors:  A M Cocolos; S Vladoiu; A Caragheorgheopol; A M Ghemigian; D Ioachim; C Poiana
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

3.  Vitamin D Status and VDR Polymorphisms as Prognostic Factors in Differentiated Thyroid Carcinoma.

Authors:  Andra-Maria Cocolos; Andrei Muresan; Andra Caragheorgheopol; Mircea Ghemigian; Dumitru Ioachim; Catalina Poiana
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

4.  Vitamin D level is not a predictor of hypocalcemia after total thyroidectomy.

Authors:  Guk Haeng Lee; Yun Hyi Ku; Hong Il Kim; Myung-Chul Lee; Min Joo Kim
Journal:  Langenbecks Arch Surg       Date:  2015-06-09       Impact factor: 3.445

5.  25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.

Authors:  Debora Lucia Seguro Danilovic; Bruno Ferraz-de-Souza; Amanda Wictky Fabri; Nathalie Oliveira Santana; Marco Aurelio Kulcsar; Claudio Roberto Cernea; Suemi Marui; Ana Oliveira Hoff
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

Review 6.  Sunshine vitamin and thyroid.

Authors:  Immacolata Cristina Nettore; Luigi Albano; Paola Ungaro; Annamaria Colao; Paolo Emidio Macchia
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

7.  Descriptive Epidemiological Analysis of Thyroid Cancer in thezzm321990Saudi Population (2001-2013)

Authors:  Bandar Alshehri
Journal:  Asian Pac J Cancer Prev       Date:  2017-05-01

Review 8.  The Role of Vitamin D in Thyroid Diseases.

Authors:  Dohee Kim
Journal:  Int J Mol Sci       Date:  2017-09-12       Impact factor: 5.923

9.  Serum 25-hydroxyvitamin D might be an independent prognostic factor for Graves disease recurrence.

Authors:  Hwa Young Ahn; Yun Jae Chung; Bo Youn Cho
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

10.  Increased thyroid malignancy in patients with primary hyperparathyroidism.

Authors:  Luchuan Li; Baoyuan Li; Bin Lv; Weili Liang; Binbin Zhang; Qingdong Zeng; Andrew G Turner; Lei Sheng
Journal:  Endocr Connect       Date:  2021-08-02       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.